Advertisement

RNA Oncogenic Virus-Associated Antigens

And Host Immune Response to Them
  • Tadao Aoki
  • Louis R. Sibal
Part of the Cancer book series (C, volume 4)

Abstract

The rapid development of analytical techniques has revealed the complexity of antigens associated with type B and type C RNA viruses. These antigens may be broadly categorized as either viral, cellular, or soluble (Aoki, 1973) (Table 1). Based on the morphological structure of viruses, which consists of an inner nucleoid and an outer shell surrounded by an envelope acquired during budding of the virus from the surface of infected cells (deHarven, 1968), viral antigens can additionally be divided into viral envelope antigens (VEAs) and intraviral antigens. Cell surface antigens (CSAs) induced by viruses and by malignant transformation (mutation of the cellular genome) possess several type specificities (Klein, 1969; Old and Boyse, 1965). To date, while viral antigens have been found intracellularly, no viral-genome-induced cellular antigens have been demonstrated there. Several groups of soluble antigens corresponding to the above specificities have been detected in the circulation and in the kidneys of virus-infected animals (see below).

Keywords

Murine Leukemia Virus Immunoelectron Microscopy Soluble Antigen Woolly Monkey Endogenous Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson, S. A., and Stephenson, J. R., 1974, Widespread natural occurrence of high titers of neutralizing antibodies to a specific class of endogenous mouse type-C virus, Proc. Natl. Acad. Sci. U.S.A. 71:1957.PubMedGoogle Scholar
  2. Aaronson, S. A., Parks, W. P., Scolnick, E. M., and Todaro, G. J., 1971a, Antibody to the RNA-dependent DNA polymerase of mammalian C-type RNA tumor viruses, Proc. Natl. Acad. Sci. U.S.A. 68:920.PubMedGoogle Scholar
  3. Aaronson, S. A., Todaro, G. J., and Scolnick, E. M., 1971b, Induction of murine C-type viruses from clonal lines of virus-free BALB/3T3 cells, Science 174:157.PubMedGoogle Scholar
  4. Aoki, T., 1971, Surface antigens of murine leukemia cells and murine leukemia viruses, Transplant. Proc. 3:1195.Google Scholar
  5. Aoki, T., 1973, An analysis of antigens on the surface of murine leukemia viruses and cells, in: Unifying Concepts of Leukemia (R. M. Dutcher and L. Chieco-Bianchi, eds.), Bibl. Haematol. (Basel) 39:307.Google Scholar
  6. Aoki, T., 1974, Murine type-C RNA viruses: A proposed reclassification, other possible pathogenicities, and a new immunologic function, J. Natl. Cancer Inst. 52:1029.PubMedGoogle Scholar
  7. Aoki, T., 1975, Surface antigens of normal and neoplastic lymphohematopoietic cells, in: Immunological Aspects of Neoplasia (E. Hersh, ed.), presented at the 26th Annual Symposium on Fundamental Cancer Research, Houston, Texas, pp. 149–167, Williams & Wilkinson, Baltimore, Md.Google Scholar
  8. Aoki, T., and Johnson, P. A., 1972, Suppression of Gross leukemia cell-surface antigens: A kind of antigenic modulation, J. Natl. Cancer Inst. 49:183.PubMedGoogle Scholar
  9. Aoki, T., and Takahashi, T., 1972, Viral and cellular surface antigens of murine leukemias and myelomas: Serological analysis by immunoelectron microscopy, J. Exp. Med. 135:443.PubMedGoogle Scholar
  10. Aoki, T., and Todaro, G. J., 1973, Antigenic properties of endogenous type-C viruses from spontaneously transformed clones of BALB/3T3, Proc. Natl. Acad. Sci. U.S.A. 70:1598.PubMedGoogle Scholar
  11. Aoki, T., Boyse, E. A., and Old, L. J., 1966, Occurrence of natural antibody to the G (Gross) leukemia antigen in mice, Cancer Res. 26:1415.PubMedGoogle Scholar
  12. Aoki, T., Boyse, E. A., and Old, L. J., 1968a, Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice, J. Natl. Cancer Inst. 41:89.PubMedGoogle Scholar
  13. Aoki, T., Boyse, E. A., and Old, L. J., 1968b, Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection, J. Natl. Cancer Inst. 41:97.PubMedGoogle Scholar
  14. Aoki, T., Boyse, E. A., and Old, L. J., 1968c, Wild-type Gross leukemia virus. III. Serological tests as indicators of leukemia risk, J. Natl. Cancer Inst. 41:103.PubMedGoogle Scholar
  15. Aoki, T., Boyse, E. A., Old, L. J., Deharven, E., Hämmerling, U., and Wood, H. A., 1970, G (Gross) and H-2 cell surface antigens: Location on Gross leukemia cells by electron microscopy with visually labeled antibody, Proc. Natl. Acad. Sci. U.S.A. 65:569.PubMedGoogle Scholar
  16. Aoki, T., Herberman, R. B., Johnson, P. A., Liu, M., and Sturm, M. M., 1972, Wild-type Gross leukemia virus: Classification of soluble antigens (GSAs), J. Virol. 10:1208.PubMedGoogle Scholar
  17. Aoki, T., Stephenson, J. R., and Aaronson, S. A., 1973a, Demonstration of a cell-surface antigen associated with murine sarcoma virus by immunoelectron microscopy, Pxoc. Natl. Acad. Sci. U.S.A. 70:742.Google Scholar
  18. Aoki, T., Potter, M., and Sturm, M. M., 1973b, Analysis of type C viruses associated with primary and short-term transplanted mouse plasma cell tumors by immunoelectron microscopy, J. Natl. Cancer Inst. 51:1609.PubMedGoogle Scholar
  19. Aoki, T., Huebner, R. J., Chang, K. S. S., Sturm, M. M., and Liu, M., 1974a, Diversity of envelope antigens on murine type C RNA viruses, J. Natl. Cancer Inst. 52:1189.PubMedGoogle Scholar
  20. Aoki, T., Kvedar, J. P., Kudo, T., Plata, E. J., Sendo, F., and Hollis, V. W., Jr., 1974b, Enhancement of host immune response to cell surface antigens by the extract of Streptococcus hemolyticus, in: Comparative Leukemia Research, 1973 (Y. Ito and R. M. Dutcher, eds.), pp. 237–240, University of Tokyo Press, Japan.Google Scholar
  21. Aoki, T., Stephenson, J. R., Aaronson, S. A., and Hsu, K. C., 1974c, Surface antigens of mammalian sarcoma virus-transformed nonproducer cells, Proc. Natl. Acad. Sci. U.S.A. (in press).Google Scholar
  22. August, J. T., Bolognesi, D. P., Fleissner, E., Gilden, R. V., and Nowinski, R. C., 1974, Letter to Editor: A proposed nomenclature for virion proteins of oncogenic RNA viruses, Virology 60:595.PubMedGoogle Scholar
  23. Baldwin, R. W., Bowen, J. G., Embleton, M. J., Price, M. R., and Robins, R. A., 1974, Serum factors modifying lymphocyte cytotoxicity for tumor cells, Adv. Biosci. 12:539.Google Scholar
  24. Batzing, B. L., Yurconic, M., Jr., and Hanna, M. G., Jr., 1974, Autogenous immunity to endogenous RNA tumor virus: Chronic humoral immune response to virus envelope antigens in B6C3F, mice, J. Natl. Cancer Inst. 52:117.PubMedGoogle Scholar
  25. Billingham, R. E., Brent, L., and Medawar, P. B., 1956, Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance, Philos. Trans. R. Soc. London 239:357.Google Scholar
  26. Borsos, T., and Rapp, H. J., eds., 1973, Conference on the use of BCG in therapy of cancer, Natl. Cancer Inst. Monogr. 39.Google Scholar
  27. Boyse, E. A., and Old, L. J., 1969, Some aspects of normal and abnormal cell surface genetics, Ann. Rev. Genet. 3:269.Google Scholar
  28. Boyse, E. A., Old, L. J., and Aoki, T., 1967, Immunogenetics of leukemia in the mouse, in: Treatment of Burkitt’s tumor (J. H. Burchenal and D. P. Burkitt, eds.), UICC Monograph Series, Vol. 8, pp. 248–257, Springer, New York.Google Scholar
  29. Chieco-Bianchi, L., Sendo, F., Aoki, T., and Barrera, O. L., 1974, Immunologic tolerance to antigens associated with murine leukemia viruses: T-cell unresponsiveness? J. Natl. Cancer Inst. 52:1345.PubMedGoogle Scholar
  30. Deharven, E., 1968, Morphology of murine leukemia viruses, in: Experimental Leukemia (M. Rich, ed.), pp. 97–129, Appleton-Century-Crofts, New York.Google Scholar
  31. Dezfulian, M., Zee, T., DE Ome, K. B., Blair, P. B., and Weiss, D. W., 1968, Role of the mammary tumor virus in the immunogenicity of spontaneous mammary carcinomas of BALB/c mice and in the responsiveness of the hosts, Cancer Res. 28:1759.PubMedGoogle Scholar
  32. Eckner, R. J., and Steeves, R. A., 1972, A classification of the murine leukemia viruses: Neutralization of pseudotype of Friend spleen focus-forming virus by type-specific murine antisera, J. Exp. Med. 136:832.PubMedGoogle Scholar
  33. Gallagher, R. E., Todaro, G. J., Smith, R. G., Livingston, D. M., and Gallo, R. C., 1974, Relationship between RNA-directed DNA polymerase (reverse transcriptase) from human acute leukemic blood cells and primate type-C viruses, Proc. Natl. Acad. Sci. U.S.A. 71:1309.PubMedGoogle Scholar
  34. Geering, G., Old, L. J., and Boyse, E. A., 1966, Antigens of leukemias induced by naturally occurring murine leukemia virus: Their relation to the antigens of Gross virus and other murine leukemia viruses, J. Exp. Med. 124:753.PubMedGoogle Scholar
  35. Geering, G., Aoki, T., and Old, L. J., 1970, Shared viral antigen of mammalian leukemia viruses, Nature (London) 226:265.Google Scholar
  36. Gilden, R. V., and Oroszlan, S., 1972, Group-specific antigens of RNA tumor viruses as markers for subinfectious expression of the RNA virus genome, Proc. Natl. Acad. Sci. U.S.A. 69:1021.PubMedGoogle Scholar
  37. Gilden, R. V., Toni, R., Hanson, M., Bova, D., Charman, H. P., and Oroszlan, S., 1974, Immunochemical studies of the major internal polypeptide of woolly monkey and gibbon ape type C viruses, J. Immunol. 112:1250.PubMedGoogle Scholar
  38. Green, M., and Gerard, G. F., 1974, RNA-directed DNA polymerase—Properties and functions in oncogenic RNA viruses and cells, in: Progress in Nucleic Acid Research and Molecular Biology, Academic Press, New York.Google Scholar
  39. Greenberger, J. S., Stephenson, J. R., Aoki, T., and Aaronson, S. A., 1974, Cell surface antigens of murine sarcoma virus transformed nonproducer cells: Further evidence for lack of transplantation immunity, Int. J. Cancer 14:145.PubMedGoogle Scholar
  40. Gregoriades, A., and Old, L. J., 1969, Isolation and some characteristics of a group-specific antigen of the murine leukemia viruses, Virology 37:189.PubMedGoogle Scholar
  41. Gross, L., 1951, Pathogenic properties, and “vertical” transmission of the mouse leukemia agent, Proc. Soc. Exp. Bid. Med. 78:342.Google Scholar
  42. Hanafusa, H., Aoki, T., Kawai, S., Miyamoto, T., and Wilsnack, R. E., 1973, Presence of antigen common to avian tumor viral envelope antigen in normal chick embryo cells, Virology 56:22.PubMedGoogle Scholar
  43. Hellström, I., Sjögren, H. O., Warner, G. A., and Hellström, K. E., 1971, Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms, Int. J. Cancer 7:226.PubMedGoogle Scholar
  44. Herberman, R. B., 1972, Serological analysis of cell surface antigens of tumors induced by murine leukemia virus, J. Natl. Cancer Inst. 48:265.PubMedGoogle Scholar
  45. Herberman, R. B., and Aoki, T., 1972, Immune and natural antibodies to syngeneic murine plasma cell tumors, J. Exp. Med. 136:94.PubMedGoogle Scholar
  46. Herberman, R. B., Aoki, T., and Nunn, M. E., 1973, Solubilization of G (Gross) antigens on the surface of G leukemia cells, J. Natl. Cancer Inst. 50:481.PubMedGoogle Scholar
  47. Herberman, R. B., Aoki, T., Nunn, M. E., Lavrin, D. H., Soares, N., Gazdar, A., Holden, H., and Chang, K. S. S., 1974, Specificity of 51Cr-release cytotoxicity by lymphocytes immune to murine sarcoma virus, J. Natl. Cancer Inst. 53:1103.PubMedGoogle Scholar
  48. Hilgers, J., Nowinski, R. C., Geering, G., and Hardy, W., 1972, Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence, Cancer Res. 32:98.PubMedGoogle Scholar
  49. Hollis, V. W., Jr., Aoki, T., Barrera, O. L., Oldstone, M. B. A., and Dixon, F. J., 1974, Detection of naturally occurring antibodies to RNA-dependent DNA polymerase of murine leukemia virus in kidney eluates of AKR mice, J. Virol. 13:448.PubMedGoogle Scholar
  50. Ikeda, H., Stockert, E., Rowe, W. P., Boyse, E. A., Lilly, F., Sato, H., Jacobbs, S., and Old, L. J., 1973, Relation of chromosome 4 (linkage group VIII) to murine leukemia virus-associated antigens of AKR mice, J. Exp. Med. 137:1103.PubMedGoogle Scholar
  51. Kassel, R. L., Old, L. J., Carswell, E. A., Fiore, N. C., and Hardy, W. D., Jr., 1973, Serum-mediated leukemia cell destruction in AKR mice: Role of complement in the phenomenon, J. Exp. Med. 138:925.PubMedGoogle Scholar
  52. Kennel, S. J., DEL Villano, B. C., Levy, R. L., and Lerner, R. A., 1973, Properties of an oncornavirus glycoprotein: Evidence for its presence on the surface of virions and infected cells, Virology 55:464.PubMedGoogle Scholar
  53. Klein, G., 1968, Tumor specific transplantation antigen, Cancer Res. 28:625.PubMedGoogle Scholar
  54. Klein, G., 1969, Tumor antigens, Ann. Rev. Microbiol. 20:223.Google Scholar
  55. Kudo, T., Aoki, T., and Morrison, J. L., 1974, Stabilization of antigens on surfaces of malignant cells by formalin treatment, J. Natl. Cancer Inst. 52:1553.PubMedGoogle Scholar
  56. Kurokawa, T., Hattori, T., and Furue, H., 1972, Clinical experiences with the streptococcal anticancer preparation, OK-432 (NSCB116209), Cancer Chemother. Rep. Part. 156:211.Google Scholar
  57. Levy, J. P., Varet, B., and Oppenheim, E., 1969, Neutralization of Graffi leukemia virus, Nature (London) 224:606.Google Scholar
  58. Lilly, F., and Nathanson, S. G., 1969, Studies on the FMR antigen, Transplant. Proc. 1:85.PubMedGoogle Scholar
  59. Lowry, D. R., Rowe, W. P., Teich, N., and Hartley, J. A., 1971, High frequency activation in vitro by 5-iododeoxyuridine, Science 174:155.Google Scholar
  60. Mcallister, R. M., Nelson-Rees, W. A., Johnson, E. Y., Rongey, R. W., and Gardner, M. B., 1971, Disseminated rhabdomyosarcoma formed in kittens by cultured human rhabdomyosarcoma cells, J. Natl. Cancer Inst. 47:603.PubMedGoogle Scholar
  61. Mellors, R. C., Shirai, T., Aoki, T., Huebner, R. J., and Krawczynski, K., 1971, Wild-type Gross leukemia viruses and the pathogenesis of the glomerulonephritis of New Zealand mice, J. Exp. Med. 133:113.PubMedGoogle Scholar
  62. Morton, D. L., Miller, G. F., and Wood, D. A., 1965, Demonstration of tumor-specific immunity against antigens unrelated to the mammary tumor virus in spontaneous mammary adenocarcinomas, J. Natl. Cancer Inst. 42:303.Google Scholar
  63. Nowinski, R. C., and Peters, E. D., 1973, Cell surface antigens associated with murine leukemia virus: Definition of the GL and GT antigenic systems, H. Virol. 12:1104.Google Scholar
  64. Nowinski, R. C., Old, L. J., Boyse, E. A., Deharven, E., and Geering, G., 1968, Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus, Virology 34:617.PubMedGoogle Scholar
  65. Nowinski, R. C., Sarkar, N. H., Old, L. J., Moore, D. H., Scheer, D. I., and Hilgers, J., 1971, Characteristics of the structural components of the mouse mammary tumor virus. II. Viral proteins and antigens, Virology 46:1.PubMedGoogle Scholar
  66. Nowinski, R. C., Fleissner, E., Sarkar, N. H., and Aoki, T., 1972, Chromatographic separation and antigenic analysis of proteins of the oncornavirus. II. Mammalian leukemia—sarcoma viruses, J. Virol. 9:359.PubMedGoogle Scholar
  67. Okabe, H., Gilden, R. V., and Hatanaka, M., 1973, Extensive homology of RD114 virus DNA with RNA of feline cell origin, Nature New Biol. 244:54.PubMedGoogle Scholar
  68. Okamoto, H., Minami, M., Shoin, S., Koshimura, S., and Shimizu, R., 1966, Experimental anticancer studies. Part XXXI. On the streptococcal preparation having potent anticancer activity, Jpn. J. Exp. Med. 36:175.PubMedGoogle Scholar
  69. Okamoto, H., Shoin, S., Koshimura, S., and Shimizu, R., 1972, ß-Hemolytic Streptococcus as a Cancer Controller, (H. Okamoto, ed.), Chugai Pharmaceutical Co., Japan.Google Scholar
  70. Old, L. J., and Boyse, E. A., 1965, Antigens of tumors and leukemias induced by viruses, Fed. Proc. 24:1009.PubMedGoogle Scholar
  71. Old, L. J., Boyse, E. A., Clarke, D. A., and Carswell, E. A., 1962, Antigenic properties of chemically induced tumors, Ann. N.Y. Acad. Sci. 101:80.Google Scholar
  72. Old, L. J., Boyse, E. A., and Stockert, E., 1964, Typing of mouse leukemias by serological methods, Nature (London) 201:777.Google Scholar
  73. Old, L. J., Boyse, E. A., and Stockert, E., 1965, The G (Gross) leukemia antigen, Cancer Res. 25:813.PubMedGoogle Scholar
  74. Old, L. J., Stockert, E., Boyse, E. A., and Kim, J. H., 1968, Antigenic modulation, loss of TL antigen from cells exposed to TL antibody: Study of the phenomenon in vitro, J. Exp. Med. 127:523.PubMedGoogle Scholar
  75. Oldstone, M. B. A., Aoki, T., and Dixon, F. J., 1972a, The antibody response of mice to murine leukemia virus in spontaneous infection: Absence of classical immunologic tolerance, Proc. Natl. Acad. Sci. U.S.A. 69:134.PubMedGoogle Scholar
  76. Oldstone, M. B. A., Tishon, A., Tonietti, G., and Dixon, F. J., 1972, Immune complex disease associated with spontaneous murine leukemia: Incidence and pathogenesis of glomerulonephritis, Clin. Immunol. Immunopathol. 1:6.Google Scholar
  77. Oroszlan, S., Fisher, C. L., Stanley, T. B., and Gilden, R. V., 1970, Proteins of the murine C-type RNA viruses. I. Isolation of a group-specific antigen by isoelectric focusing, J. Gen. Virol. 8:1.PubMedGoogle Scholar
  78. Ortaldo, J. R., Ting, C. C., and Herberman, R. B., 1974, Modulation of fetal antigen(s) in mouse leukemia cells, Cancer Res. 34:1366.PubMedGoogle Scholar
  79. Ortez de Landazuri, M., Kedar, E., and Fahey, J. L., 1974, Studies of antibody dependent cellular cytotoxicity (ADCC) to a syngeneic Gross virus-induced lymphoma, J. Natl. Cancer Inst. 52:147.Google Scholar
  80. Parks, W. P., and Scolnick, E. M., 1972, Radioimmunoassay of mammalian type C viral protein: Interspecies antigenic reactivities of the major internal polypeptide, Proc. Natl. Acad. Sci. U.S.A. 69:1766.PubMedGoogle Scholar
  81. Parks, W. P., Scolnick, E. M., Ross, J., Todaro, G. J., and Aaronson, S. A., 1972, Immunological relationships of reverse transcriptases from ribonucleic acid tumor viruses, J. Virol. 9:110.PubMedGoogle Scholar
  82. Parks, W. P., Howk, R. S., Scolnick, E. K., Oroszlan, S., and Gilden, R. V., 1974, Immunochemical characterization of two major polypeptides from murine mammary tumor virus, J. Virol. 13:1200.PubMedGoogle Scholar
  83. Plata, E. J., Aoki, T., Collins, F., and Sibal, L. R., 1973, Mammary tumor virus (MTV): Soluble antigen (MSA) in the plasma of infected mice, Annual Meeting of the American Society of Microbiology, abst. 133, p. 216.Google Scholar
  84. Pourrean-Schneider, N., Stephens, R. J., and Gardner, W. U., 1968, Viral inclusions and other cytoplasmic components in a Leydig cell murine tumor: An electron microscopic study, Int. J. Cancer 3:155.Google Scholar
  85. Salaman, M. H., and Wedderburn, N., 1966, The immunodepressive effect of Friend virus, Immunology 10:445.Google Scholar
  86. Schäfer, W., Sźantó, J., Anderer, F. A., Frank, H., Gelderblom, H., Lange, J., and Pister, L., 1970, Tests for mouse leukemia viruses and isolation of some of their components, in: Comparative Leukemia Research (R. M. Dutcher, ed.), pp. 327–332, Karger, New York.Google Scholar
  87. Sherr, C. J., Lieber, M. M., Benveniste, R. E., and Todaro, G. J., 1974, Endogenous baboon type C virus (M7): Biochemical and immunologic characterization, Virology 58:492.PubMedGoogle Scholar
  88. Silobreic, V., and Suit, H. D., 1967, Tumor specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. I. Quantitative cell transplants into mammary-tumor-agent-positive and free mice, J. Natl. Cancer Inst. 39:1113.Google Scholar
  89. Sjögren, H. O., Hellström, I., Bansal, S. C., and Hellström, K. E., 1971, Suggestive evidence that the “blocking antibodies” of tumor bearing individuals may be antigen-antibody complexes, Proc. Natl. Acad. Sci. U.S.A. 68:1372.PubMedGoogle Scholar
  90. Snell, G. D., and Stimpfling, J. H., 1966, Genetics of tissue transplantation, in: The Biology of the Laboratory Mouse (E. L. Green, ed.), pp. 457–492, McGraw-Hill, New York.Google Scholar
  91. Southam, C. M., 1960, Relationships of immunology to cancer, a review, Cancer Res. 20:271.PubMedGoogle Scholar
  92. Stephenson, J. R., Tronick, S. R., Reynolds, R. K., and Aaronson, S. A., 1974, Isolation and characterization of C-type viral gene products of virus-negative mouse cells, J. Exp. Med. 139:427.PubMedGoogle Scholar
  93. Stockert, E., Old, L. J., and Boyse, E. A., 1971, The GIX system: A cell surface alloantigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome, J. Exp. Med. 133:1334.PubMedGoogle Scholar
  94. Strand, M., and August, J. T., 1973, Structural proteins of oncogenic ribonucleic acid viruses: Interspec II, a new interspecies antigen, J. Biol. Chem. 248:5627.PubMedGoogle Scholar
  95. Strand, M., and August, J. T., 1974, Structural proteins of mammalian oncogenic RNA viruses: Multiple antigenic determinants of the major internal protein and envelope glycoprotein, J. Virol. 13:171.PubMedGoogle Scholar
  96. Stück, B., Old, L. J., and Boyse, E. A., 1964a, Occurrence of soluble antigen in the plasma of mice with virus-induced leukemia, Proc. Natl. Acad. Sci. U.S.A. 52:950.Google Scholar
  97. Stück, B., Old, L. J., and Boyse, E. A., 1964b, Antigenic conversion of established leukemias by an unrelated leukemogenic virus, Nature (London) 202:1016.Google Scholar
  98. Suit, H. D., and Silobreic, V., 1967, Tumor specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. II. Active immunization of mammary-tumor-agent-free mice, J. Natl. Cancer Inst. 39:1121.PubMedGoogle Scholar
  99. Teramoto, Y. A., Puentes, M. J., Young, L. J. T., and Cardiff, R. D., 1974, Structure of the mouse mammary tumor virus: Polypeptides and glycoproteins, J. Virol. 13:411.PubMedGoogle Scholar
  100. Ting, C. C., and Herberman, R. B., 1974, Serological analysis of the immune response to Friend virus-induced leukemia, Cancer Res. 34:1676.PubMedGoogle Scholar
  101. Ting, C. C., Shiu, G., Rodrigues, D., and Herberman, R. B., 1974, Cell-mediated immunity to Friend virus-induced leukemia, Cancer Res. 34:1684.PubMedGoogle Scholar
  102. Todaro, G. J., 1972, “Spontaneous” release of type C viruses from clonal lines of “spontaneously” transformed BALB/3T3 cells, Nature (London) 240:157.Google Scholar
  103. Tronick, S. R., Stephenson, J. R., and Aaronson, S. A., 1973, Immunological characterization of a low molecular weight polypeptide of murine leukemia virus, Virology 54:199.PubMedGoogle Scholar
  104. Tronick, S. R., Stephenson, J. R., and Aaronson, S. A., 1974, Comparative immunological studies of RNA C-type viruses: Radioimmunoassay for a low molecular Weight polypeptide of woolly monkey leukemia virus, Virology 57:347.PubMedGoogle Scholar
  105. Vaage, J., 1968a, Non-virus-associated antigens in virus-induced mouse mammary tumors, Cancer Res. 28:2477.PubMedGoogle Scholar
  106. Vaage, J., 1968b, Non-cross-reacting resistance to virus-induced mouse mammary tumors in virus-infected C3H mice, Nature (London) 218:101.Google Scholar
  107. Wedderburn, N., and Salaman, N. H., 1968, The immunodepressive effect of Friend virus. II. Reduction of splenic hemolysin-producing cells in primary and secondary responses, Immunology 15:439.PubMedGoogle Scholar
  108. Yoshiki, T., Mellors, R. C., Hardy, W. D., Jr., and Fleissner, E., 1964, Common cell surface antigens associated with mammalian C-type RNA viruses: Cell membrane-bound gs antigen, J. Exp. Med. 139:925.Google Scholar
  109. Yoshiki, T., Mellors, R. C., and Hardy, W. D., Jr., 1973, Common cell-surface antigen associated with murine and feline C-type RNA leukemia viruses, Proc. Natl. Acad. Sci. U.S.A. 7:1878.Google Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • Tadao Aoki
    • 1
  • Louis R. Sibal
    • 1
  1. 1.Viral Oncology Area, Division of Cancer Cause and PreventionNational Cancer Institute, NIHBethesdaUSA

Personalised recommendations